Analyst Price Targets — BIOX
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| January 2, 2026 11:24 am | Austin Moeller | Canaccord Genuity | $2.00 | $1.31 | TheFly | Bioceres price target lowered to $2 from $2.25 at Canaccord |
| September 10, 2025 12:24 pm | Ben Klieve | Lake Street | $5.00 | $2.06 | TheFly | Bioceres price target lowered to $5 from $8 at Lake Street |
| September 10, 2025 9:01 am | — | Canaccord Genuity | $2.50 | $2.06 | TheFly | Bioceres downgraded to Hold from Buy at Canaccord |
| September 9, 2025 6:40 pm | — | Oppenheimer | $5.00 | $2.24 | StreetInsider | Bioceres Crop Solutions (BIOX) PT Lowered to $5 at OppenheimerMember Login |
| October 21, 2024 7:33 am | Kristen Owen | Oppenheimer | $13.00 | $7.51 | StreetInsider | Bioceres Crop Solutions (BIOX) PT Lowered to $13 at Oppenheimer |
| September 11, 2024 8:17 am | Ben Klieve | Loop Capital Markets | $13.00 | $8.31 | StreetInsider | Bioceres Crop Solutions (BIOX) PT Lowered to $13 at Lake Street Capital Markets |
| September 11, 2024 8:01 am | Ben Klieve | Lake Street | $13.00 | $8.65 | TheFly | Bioceres price target lowered to $13 from $25 at Lake Street |
| September 11, 2024 6:57 am | Austin Moeller | Canaccord Genuity | $12.50 | $8.36 | StreetInsider | Bioceres Crop Solutions (BIOX) PT Lowered to $12.50 at Canaccord Genuity |
| September 10, 2024 4:03 pm | Kristen Owen | Oppenheimer | $16.00 | $8.65 | StreetInsider | Bioceres Crop Solutions (BIOX) PT Lowered to $16 at Oppenheimer |
| July 2, 2024 7:40 am | Scott Fortune | Roth Capital | $15.00 | $11.13 | TheFly | Bioceres resumed with a Buy at Roth MKM |
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for BIOX

Bioceres Crop Solutions Corp. (BIOX) Q3 2026 Earnings Call Transcript

Bioceres Crop (BIOX) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to a loss of $0.02 per share a year ago.

ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ: BIOX), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, announced financial results for the fiscal third quarter ended March 31, 2026. Financial results are expressed in U.S. dollars and are presented in…

ROSARIO, Argentina--(BUSINESS WIRE)--The dial-in details of release dated May 4, 2026 have been revised. The US Toll Free dial-in number should read 1-833-461-5787; the International dial-in numbers link has been updated; and the Conference ID: should read 717574163. The updated release reads: BIOCERES CROP SOLUTIONS TO HOST FISCAL THIRD QUARTER 2026 FINANCIAL RESULTS CONFERENCE CALL ON TUESDAY, MAY 12, 2026 AT 8:30…

ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (NASDAQ: BIOX) (“Bioceres” or the “Company”), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, will hold a conference call on Tuesday, May 12, 2026 at 8:30 a.m. Eastern Time to discuss its results for the fiscal third quarter…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for BIOX.
U.S. House Trading
No House trades found for BIOX.
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
